The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEGERION PHARMACEUTICALSAEGR 2 08/15/19 | NOTE 2.000% 8/1 | 00767EAB8 | 6,032 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 6,999 | 984,329 | SH | SOLE | 984,329 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 2,124 | 505,736 | SH | SOLE | 505,736 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 6,873 | 6,483,610 | SH | SOLE | 6,483,610 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 19,647 | 946,379 | SH | SOLE | 946,379 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 9,651 | 2,580,518 | SH | SOLE | 2,580,518 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM | 03835L108 | 3,505 | 3,894,219 | SH | SOLE | 3,894,219 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 8,159 | 1,539,437 | SH | SOLE | 1,539,437 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 1,560 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 909 | 60,045 | SH | SOLE | 60,045 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 6,983 | 1,201,975 | SH | SOLE | 1,201,975 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 3,881 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 1,135 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| EMERGENT BIOSOLUTIONS INC | COM | 29089Q105 | 2,364 | 46,800 | SH | SOLE | 46,800 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 5,811 | 60,840 | SH | SOLE | 60,840 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,738 | 730,004 | SH | SOLE | 730,004 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 7,089 | 2,835,786 | SH | SOLE | 2,835,786 | 0 | 0 | ||
| INTERPACE DIAGNOSTICS GROUP | COM NEW | 46062X204 | 1,147 | 1,434,030 | SH | SOLE | 1,434,030 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 18,857 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MATINAS BIOPHARMA HOLDINGS I | COM | 576810105 | 2,189 | 2,008,006 | SH | SOLE | 2,008,006 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 11,775 | 4,511,504 | SH | SOLE | 4,511,504 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 5,746 | 4,074,944 | SH | SOLE | 4,074,944 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 3,869 | 294,894 | SH | SOLE | 294,894 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 2,192 | 127,224 | SH | SOLE | 127,224 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 932 | 187,074 | SH | SOLE | 187,074 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 3,199 | 3,403,402 | SH | SOLE | 3,403,402 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 23,189 | 1,260,288 | SH | SOLE | 1,260,288 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 1,480 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,004 | 98,860 | SH | SOLE | 98,860 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 2,816 | 227,430 | SH | SOLE | 227,430 | 0 | 0 | ||